Literature DB >> 11874747

Clinician change detection viewing longitudinal stereophotographs compared to confocal scanning laser tomography in the LSU Experimental Glaucoma (LEG) Study.

John C Ervin1, Hans G Lemij, Richard P Mills, Harry A Quigley, Hilary W Thompson, Claude F Burgoyne.   

Abstract

PURPOSE: To compare optic nerve head (ONH) surface change detection by confocal scanning laser tomography (CSLT) within the LSU Experimental Glaucoma (LEG) study to expert clinicians viewing the LEG stereophotographs.
DESIGN: Experimental study. PARTICIPANTS: Four fellowship-trained glaucoma specialists.
METHODS: In the LEG study, six 15 CSLT images (TopSS, Laser Diagnostics Technologies, San Diego, CA) and four 2x optic disc stereophotographs were obtained from both eyes of 12 monkeys on 3 separate days and then every 2 weeks after laser to one eye (study eye) to elevate intraocular pressure. ONH surface change detection within the CSLT images is described in our companion report. In this report, the preliminary study compared change detection by the CSLT multivariate strategy with that of a single clinician viewing stereophotograph pairs on three separate occasions as the "gold standard." The main study compared change detection by three additional clinicians viewing a subset of LEG stereophotograph pairs on three separate occasions with that of the CSLT multivariate strategy as the "gold standard." Clinician change detection was assessed for partial (two of three occasions) or complete (three of three occasions) agreement. Three comparison groups within the main study are emphasized: 44 group A comparisons assessed false-positive change detection (specificity); 38 group B comparisons assessed change detection within 38 instances (11 onset and 27 progression events) of CSLT-detected study eye change; and 30 group C comparisons assessed change detection within 30 instances in which the CSLT failed to detect change in study eyes. MAIN OUTCOME MEASURES: Clinician change detection within each comparison with either partial or complete agreement.
RESULTS: Within the main study, intrareading (-.29 to 0.67) and interreading (0.24--0.56) session agreement for each clinician was slight to moderate by kappa test. Good specificity (less than 10% false-positive change detection) was achieved within the 44 group A comparisons by two of the three clinicians, but only when the more stringent criterion (change detection on three of three occasions) was applied. Of the 38 group B comparisons (in which the CSLT detected change), the two clinicians who achieved good specificity in group A failed to detect change in 25 and 16 instances, respectively, using the more stringent (three of three) criterion. Similarly, of the 30 group C comparisons (in which the CSLT failed to detect change), these two clinicians detected change in three and seven instances, respectively, but in only one comparison did they both detect change.
CONCLUSIONS: This study provides the first direct evidence that an existing CSLT may reasonably meet or exceed the ONH surface change detection performance of fellowship-trained glaucoma specialists in at least those eyes with good CSLT reproducibility.

Entities:  

Mesh:

Year:  2002        PMID: 11874747     DOI: 10.1016/s0161-6420(01)01004-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  11 in total

1.  Glaucomatous progression in series of stereoscopic photographs and Heidelberg retina tomograph images.

Authors:  Neil O'Leary; David P Crabb; Steven L Mansberger; Brad Fortune; Michael D Twa; Michael J Lloyd; Aachal Kotecha; David F Garway-Heath; George A Cioffi; Chris A Johnson
Journal:  Arch Ophthalmol       Date:  2010-05

Review 2.  Role of optic nerve imaging in glaucoma clinical practice and clinical trials.

Authors:  David S Greenfield; Robert N Weinreb
Journal:  Am J Ophthalmol       Date:  2008-03-04       Impact factor: 5.258

3.  The non-human primate experimental glaucoma model.

Authors:  Claude F Burgoyne
Journal:  Exp Eye Res       Date:  2015-06-09       Impact factor: 3.467

4.  Optic disc topographic parameters measured in the normal cynomolgus monkey by confocal scanning laser tomography.

Authors:  T Taniguchi; M Shimazawa; M Araie; G Tomita; M Sasaoka; Y Kitazawa; H Hara
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

5.  Evaluation of optic nerve head and retinal nerve fiber layer in early and advance glaucoma using frequency-domain optical coherence tomography.

Authors:  Songfeng Li; Xiaozhen Wang; Shuning Li; Gewei Wu; Ningli Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-11-25       Impact factor: 3.117

6.  Agreement in identification of glaucomatous progression between the optic disc photography and Heidelberg retina tomography in young glaucomatous patients.

Authors:  Paraskeva Hentova-Sencanic; Ivan Sencanic; Goran Trajković; Marija Bozic; Nevena Bjelovic
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

7.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

8.  Clinical significance of optic disc progression by topographic change analysis maps in glaucoma: an 8-year follow-up study.

Authors:  D Kourkoutas; Y M Buys; J G Flanagan; N Karamaounas; G Georgopoulos; E Iliakis; M M Moschos; G E Trope
Journal:  J Ophthalmol       Date:  2014-01-21       Impact factor: 1.909

9.  A Novel Tree Shrew (Tupaia belangeri) Model of Glaucoma.

Authors:  Brian C Samuels; John T Siegwart; Wenjie Zhan; Lisa Hethcox; Melissa Chimento; Ryan Whitley; J Crawford Downs; Christopher A Girkin
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-06-01       Impact factor: 4.799

10.  Summary of Glaucoma Diagnostic Testing Accuracy: An Evidence-Based Meta-Analysis.

Authors:  Saad Ahmed; Zainab Khan; Francie Si; Alex Mao; Irene Pan; Fatemeh Yazdi; Alexander Tsertsvadze; Cindy Hutnik; David Moher; David Tingey; Graham E Trope; Karim F Damji; Jean-Eric Tarride; Ron Goeree; William Hodge
Journal:  J Clin Med Res       Date:  2016-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.